Literature DB >> 3401794

Analgesic effects of intrathecally applied noradrenergic compounds in the developing rat: differences due to thermal vs mechanical nociception.

H E Hughes1, G A Barr.   

Abstract

Peak noradrenergic receptor development in rat spinal cord has been shown to occur around 12 days of postnatal life. The intent of the present study was to examine the development of analgesia produced by spinally applied noradrenergic agonists. The extent to which these drugs modulate pain information evoked by a thermal vs mechanical stimulus in the infant rat was also addressed. Intrathecal norepinephrine resulted in analgesia that was more pronounced against a mechanical than thermal stimulus and more pronounced in 10-day-olds than 3-day-olds. The alpha 2 receptor agonist clonidine produced a dose-dependent analgesia that first appeared at 7 days of age when tested with a thermal stimulus and 3 days of age when tested with a mechanical stimulus. The analgesic effect of clonidine was also greatest at 10 days of age. The alpha 1 agonist phenylephrine was without analgesic effects. The developmental profile of behavioral analgesia correlates with the ontogeny of noradrenergic receptor activity in the spinal cord. The finding that intrathecal norepinephrine produced a more pronounced analgesia against a mechanical rather than thermal stimulus in the adult is supported by our investigation in the infant rat.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3401794     DOI: 10.1016/0165-3806(88)90174-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Validation of a preclinical spinal safety model: effects of intrathecal morphine in the neonatal rat.

Authors:  B David Westin; Suellen M Walker; Ronald Deumens; Marjorie Grafe; Tony L Yaksh
Journal:  Anesthesiology       Date:  2010-07       Impact factor: 7.892

2.  Intrathecal clonidine in the neonatal rat: dose-dependent analgesia and evaluation of spinal apoptosis and toxicity.

Authors:  Suellen M Walker; Marjorie Grafe; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-03-30       Impact factor: 5.108

3.  Analgesia induced by localized injection of opiate peptides into the brain of infant rats.

Authors:  G A Barr; S Wang
Journal:  Eur J Pain       Date:  2012-12-03       Impact factor: 3.931

Review 4.  Neuraxial analgesia in neonates and infants: a review of clinical and preclinical strategies for the development of safety and efficacy data.

Authors:  Suellen M Walker; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

5.  Differential effects of the novel analgesic, S 12813-4, on the spinal release of substance P- and calcitonin gene-related peptide-like materials in the rat.

Authors:  E Collin; D Frechilla; M Pohl; S Bourgoin; A Mauborgne; M Hamon; F Cesselin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

6.  Developmental Changes in Pain and Spinal Immune Gene Expression after Radicular Trauma in the Rat.

Authors:  Gordon A Barr; Shaoning Wang; Christine L Weisshaar; Beth A Winkelstein
Journal:  Front Neurol       Date:  2016-12-15       Impact factor: 4.003

7.  Contribution of CD137L to Sensory Hypersensitivity in a Murine Model of Neuropathic Pain.

Authors:  Alexa A Wakley; Reno Leeming; Jenn Malon; Taxiarhia J Arabatzis; Woon Yuen Koh; Ling Cao
Journal:  eNeuro       Date:  2018-11-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.